TACC3 and cancer: Here, we demonstrated, for the first time, that TACC3 is a novel CA-directed dependency that is overexpressed at mRNA and protein levels in high CA tumors, as determined by both mRNA-based scoring and protein-based immunostaining approaches and associated with worse clinical outcome in cancer patients with CA.